指南与共识神经核医学

评估FDG-PET诊断准确性研究以制定痴呆临床使用建议

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia.
指南 / 共识 · Eur J Nucl Med Mol Imaging · 2018-04-30

基于21项文献检索的PICO问题,评估FDG-PET诊断痴呆的证据质量并供Delphi专家制定欧洲临床使用建议。1435篇文献中仅58篇进入详细评估,多数缺乏验证性性能指标、合适金标准及与临床诊断的头对头比较,方法学局限使无法从证据中推导建议。专家据现有数据给出临时建议。

要点

  • 1435篇文献中仅58篇进入详细评估,多数缺乏验证性性能指标与合适金标准。
  • 仅24%论文有独立金标准,38%使用可接受的参考标准(临床随访)。
  • 方法学局限使无法从证据推导FDG-PET增量诊断价值建议。

核心结论

  • 无法从当前文献推导FDG-PET相对于临床诊断的增量诊断价值或其缺失。
  • 方法学局限使无法从证据中推导建议,现有数据提供给专家临床医生以定义临时建议。

研究设计与样本

  • 基于公认方法学指南,定义FDG-PET特异的证据质量评估域,用于21项文献检索所对应的21个PICO问题。
  • 对每个PICO问题的发现进行排序,并供专家进行Delphi决策以推荐临床使用。

主要发现

  • 1435篇检索文献中仅58篇进入详细评估。
  • 仅两项研究评估了对照(临床诊断)相对于任何金标准/参考标准的准确性。
  • 关于指标试验(基于FDG-PET的诊断),24%的评估论文有独立金标准。
  • 38%使用可接受的参考标准(临床随访),38%仅将基于FDG-PET的诊断与基线临床诊断比较。

临床怎么用

  • 原文未据此给出推荐,仅将现有数据提供给专家临床医生以定义临时建议。

局限性

  • 多数研究缺乏验证性测试性能指标、合适金标准及FDG-PET与临床诊断的头对头比较。
  • 仅两项研究评估了对照(临床诊断)相对于任何金标准/参考标准的准确性。
  • 仅24%的评估论文有独立金标准,38%使用可接受的参考标准(临床随访),38%仅将基于FDG-PET的诊断与基线临床诊断比较。
  • 这些方法学局限使无法从证据中推导建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: FDG-PET is frequently used as a marker of synaptic damage to diagnose dementing neurodegenerative disorders. We aimed to adapt the items of evidence quality to FDG-PET diagnostic studies, and assess the evidence available in current literature to assist Delphi decisions for European recommendations for clinical use. METHODS: Based on acknowledged methodological guidance, we defined the domains, specific to FDG-PET, required to assess the quality of evidence in 21 literature searches addressing as many Population Intervention Comparison Outcome (PICO) questions. We ranked findings for each PICO and fed experts making Delphi decisions for recommending clinical use. RESULTS: Among the 1435 retrieved studies, most lacked validated measures of test performance, an adequate gold standard, and head-to-head comparison of FDG-PET and clinical diagnosis, and only 58 entered detailed assessment. Only two studies assessed the accuracy of the comparator (clinical diagnosis) versus any kind of gold-/reference-standard. As to the index-test (FDG-PET-based diagnosis), an independent gold-standard was available in 24% of the examined papers; 38% used an acceptable reference-standard (clinical follow-up); and 38% compared FDG-PET-based diagnosis only to baseline clinical diagnosis. These methodological limitations did not allow for deriving recommendations from evidence. DISCUSSION: An incremental diagnostic value of FDG-PET versus clinical diagnosis or lack thereof cannot be derived from the current literature. Many of the observed limitations may easily be overcome, and we outlined them as research priorities to improve the quality of current evidence. Such improvement is necessary to outline evidence-based guidelines. The available data were anyway provided to expert clinicians who defined interim recommendations.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Boccardi M, Festari C, Altomare D, et al. Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. Eur J Nucl Med Mol Imaging. 2018. PMID: 29713763. doi:10.1007/s00259-018-4024-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。